Amferia has been recognised by numerous organisations for its innovative research, entrepreneurial drive, business traction in multiple sectors and swift progress towards clinical translation.
During 2019, Venture Cup Sweden named Amferia as the ‘Startup-of-the year’ while the scientific journal Nature named Amferia as ‘one-to-watch’ — on a list of the top 44 pioneering university spin-offs with excellent scientific groundwork.
Amferia’s Co-founder and Sales Director, Dr. Saba Atefyekta, was recognised as a pioneering female entrepreneur by Women-in Tech Sweden and the Prince Daniel Fellowship.
